Informační systém MU
MLČOCHOVÁ, Hana, Táňa MACHÁČKOVÁ, Anja RABIEN, Lenka RADOVÁ, Pavel FABIAN, Robert ILIEV, Kateřina SLABÁ, Alexandr POPRACH, Ergin KILIC, Michal STANIK, Martina LOJOVÁ, Marek SVOBODA, Jan DOLEZEL, Rostislav VYZULA, Klaus JUNG and Ondřej SLABÝ. Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma. Scientific Reports. LONDON: NATURE PUBLISHING GROUP, 2016, vol. 6, August, p. nestránkováno, 12 pp. ISSN 2045-2322. Available from: https://dx.doi.org/10.1038/srep31852.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma
Authors MLČOCHOVÁ, Hana (203 Czech Republic, belonging to the institution), Táňa MACHÁČKOVÁ (203 Czech Republic, belonging to the institution), Anja RABIEN (276 Germany), Lenka RADOVÁ (203 Czech Republic, belonging to the institution), Pavel FABIAN (203 Czech Republic), Robert ILIEV (203 Czech Republic, belonging to the institution), Kateřina SLABÁ (203 Czech Republic, belonging to the institution), Alexandr POPRACH (203 Czech Republic, belonging to the institution), Ergin KILIC (276 Germany), Michal STANIK (203 Czech Republic), Martina LOJOVÁ (203 Czech Republic, belonging to the institution), Marek SVOBODA (203 Czech Republic, belonging to the institution), Jan DOLEZEL (203 Czech Republic), Rostislav VYZULA (203 Czech Republic, belonging to the institution), Klaus JUNG (276 Germany) and Ondřej SLABÝ (203 Czech Republic, guarantor, belonging to the institution).
Edition Scientific Reports, LONDON, NATURE PUBLISHING GROUP, 2016, 2045-2322.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.259
RIV identification code RIV/00216224:14740/16:00088919
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1038/srep31852
UT WoS 000381767500001
Keywords in English CANCER; GENE; EXPRESSION; PATHWAYS; TARGETS; PROTEIN; FREM1
Tags rivok
Tags Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 26/4/2021 13:30.
Abstract
Clear-cell renal cell carcinomas (ccRCCs) are genetically heterogeneous tumors presenting diverse clinical courses. Epithelial-mesenchymal transition (EMT) is a crucial process involved in initiation of metastatic cascade. The aim of our study was to identify an integrated miRNA/mRNA signature associated with metastasis and prognosis in ccRCC through targeted approach based on analysis of miRNAs/mRNAs associated with EMT. A cohort of 230 ccRCC was included in our study and further divided into discovery, training and validation cohorts. EMT markers were evaluated in ccRCC tumor samples, which were grouped accordingly to EMT status. By use of large-scale miRNA/mRNA expression profiling, we identified miRNA/mRNA with significantly different expression in EMT-positive tumors and selected 41 miRNAs/mRNAs for training phase of the study to evaluate their diagnostic and prognostic potential. Fifteen miRNAs/mRNAs were analyzed in the validation phase, where all evaluated miRNA/mRNA candidates were confirmed to be significantly deregulated in tumor tissue. Some of them significantly differed in metastatic tumors, correlated with clinical stage, with Fuhrman grade and with overall survival. Further, we established an EMT-based stage-independent prognostic scoring system enabling identification of ccRCC patients at high-risk of cancer-related death. Finally, we confirmed involvement of miR-429 in EMT regulation in RCC cells in vitro.
Links
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
NT13547, research and development projectName: Studium mikroRNA a genů asociovaných s procesem epiteliálně-mezenchymální tranzice jako potenciálních markerů pro predikci rizika a časný záchyt metastazování u pacientů s renálním karcinomem
90089, large research infrastructuresName: BBMRI-CZ II
Displayed: 31/8/2024 22:19